Celltrion
068270.KS
#749
Rank
A$42.34 B
Marketcap
$205.92
Share price
1.25%
Change (1 day)
9.70%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.50

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $4.62. In 2022 the company made an earnings per share (EPS) of $4.50 a decrease over its 2021 EPS that were of $5.34.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.500.02%
2022$4.50-15.84%
2021$5.3412.77%
2020$4.7470.79%
2019$2.7715.63%
2018$2.40-33.13%
2017$3.59141.17%
2016$1.498.28%
2015$1.3711.28%
2014$1.2316.37%
2013$1.06-67.42%
2012$3.2684.22%
2011$1.7762.13%
2010$1.0980.61%
2009$0.60-559.63%
2008-$0.13-123.16%
2007$0.57